Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 774 across all filing types
Latest filing 2023-01-24 Capital/Financing Update
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Capital/Financing Update Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding the grant of Employee Stock Options and Restricted Stock Units under the company's Employee Stock Option Plan. It details the number of options granted, pricing formula, vesting schedule, and other terms related to the stock options. There is no financial performance data, earnings information, or report attached. The document is an announcement of a capital-related event (grant of stock options) under regulatory compliance (SEBI Listing Regulations). This fits the category of Capital/Financing Update (CAP) as it relates to changes in the company's capital structure through stock option grants.
2023-01-24 English
Financial Result Updates
Regulatory Filings
2023-01-24 English
Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges informing about a USFDA inspection at the company's manufacturing facility. It mentions the issuance of Form 483 with observations and the company's commitment to compliance. The document is an announcement of a regulatory inspection and related observations, not a financial report, earnings release, or management discussion. It is a regulatory update related to compliance and inspection results. The document length is short (1476 characters) and it serves as an informational announcement to the stock exchanges. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-01-23 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a notification letter addressed to stock exchanges about an upcoming earnings conference call for unaudited financial results for the quarter and nine months ended December 31, 2022. It includes details about the call schedule, participants, dial-in numbers, and a safe harbor statement about forward-looking statements. The document does not contain actual financial results or detailed financial analysis but serves as an announcement of the earnings call event. According to the classification rules, such notifications about earnings calls are classified as Call Transcript (CT) if they contain the transcript, but this document is only an announcement of the call, not the transcript itself. However, since the document is specifically about the earnings conference call and not the earnings release itself, and it is not a report publication announcement or regulatory filing, the best fit is Call Transcript (CT) category as it relates to the earnings call event. Confidence is high because the document explicitly states it is an intimation of an earnings conference call and provides call details, which matches the CT category definition.
2023-01-17 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a short notice addressed to stock exchanges informing about a scheduled Board Meeting to consider and approve unaudited financial results for a quarter and nine months period. It references compliance with SEBI Listing Regulations and mentions the closure of the trading window. The document does not contain any financial data or results itself, nor does it include detailed financial statements or analysis. It is an announcement of an upcoming event (Board Meeting) related to financial results, not the results or report itself. The document length is only 1527 characters, indicating it is a brief notice. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement rather than an Interim Report (IR) or Earnings Release (ER).
2023-01-11 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2022. It is addressed to stock exchanges and confirms compliance by the registrar and transfer agent. The document is short (1314 characters) and primarily a certification letter without substantive financial data or detailed report content. It does not contain financial statements or analysis, nor is it a full report. Therefore, it fits the criteria for a Regulatory Filing (RNS) as it is a compliance certificate and not a financial report or announcement of a report publication.
2023-01-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.